The results obtained indicate that the concentration of cell-free DNA in plasma and the methylation of specific genes (such as FHIT, APC, and RASSF1) can be a significant addition to serological tumor markers in the identification of patients with renal cancer. The gene discussed is FHIT; the disease is renal carcinoma.